You are utilizing a browser that may not supported by Facebook, so we've redirected you to a simpler version to supply you with the finest experience.It is the only anti-IL7R? plan up to now with clinical information showing impact on important T-cell subpopulations, underscoring its possible applicability inside a broad selection of T-mobile media